# Resonance Health Analysis Services Pty, Ltd.

- Location (FDA's records): Perth, AU
- FDA decisions: 7 (2011–2023): 6 510(k) clearances and 1 De Novo grant
- Product codes: LNH (3), PCS (3), LLZ (1)
- Predicates its devices cite: 10 (6 its own); citations of its devices by later devices: 6 (6 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Inner Vision Biometrics Pty, Ltd.: 2 (https://510kreport.com/company/inner-vision-biometrics)
- GE Medical Systems: 1 (https://510kreport.com/company/ge-medical-systems)
- Cardiovascular Imaging Solutions, Ltd.: 1 (https://510kreport.com/company/cardiovascular-imaging-solutions)

## Its most-cited devices
- K201039: HepaFat-AI (2020), cited by 2
- K122035: Hepafat Scan (2013), cited by 2
- K182218: FerriSmart Analysis System (2018), cited by 1
- DEN130012: Ferriscan R2-Mri Analysis System (2013), cited by 1

## Recent decisions
- K231459: HepaFatSmart (V2.0.0) (Jun 20, 2023)
- K213776: LiverSmart (Dec 29, 2021)
- K201039: HepaFat-AI (Dec 7, 2020)
- K182218: FerriSmart Analysis System (Nov 30, 2018)
- K122035: Hepafat Scan (Dec 13, 2013)
- DEN130012: Ferriscan R2-Mri Analysis System (Jan 23, 2013)
- K111222: Mri-Q System (Jul 28, 2011)

Source page: https://510kreport.com/company/resonance-health-analysis-services